RxDoctor Payments Data

Marcelo di Carli, MD

Nuclear Cardiology · Boston, MANPI 1407841034

Payments from drug & device makers

$1,212,443in general payments, 2019–2025

Across 17 payments — averaging $71,320 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$1.2M
  • Sun Pharmaceutical Industries Inc.$28K
  • GE HealthCare$11K
  • Pfizer$2K
  • Sanofi-aventis U.S. LLC$1K

What the payments were for

  • Consulting fees$3,03242%
  • Speaking & faculty fees$3,85254%
  • Food & beverage$3114%

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead6$1,170,000
Sun Pharmaceutical Industries Inc.1$28,468
GE HealthCare7$10,842
Pfizer2$1,701
Sanofi-aventis U.S. LLC1$1,432

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few nuclear cardiology providers in Massachusettsto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$71,803
Medicare patients
629
Services billed
1,919

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear cardiology in Boston

Where these figures come from

Is this you, or does something look wrong? →